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Caspase-8 inactivation drives autophagy-dependent
inflammasome activation in myeloid cells
Yung-Hsuan Wu1, Shu-Ting Mo1, I-Ting Chen1, Fu-Yi Hsieh1, Shie-Liang Hsieh2,
Jinake Zhang3, Ming-Zong Lai1*

INTRODUCTION

Caspase-8 was first identified as an initiator caspase of extrinsic
apoptosis (1, 2). Extracellular stimuli, such as FasL, induce caspase-8
activation through the binding of caspase-8 and adaptor FADD to
death receptor (3). Active caspase-8 then induces activation of effector caspase-3, caspase-6, and caspase-7 for the execution of apoptosis.
Caspase-8 also inhibits necroptosis by cleaving receptor-interacting
protein kinase 1 (RIPK1) and possibly RIPK3. Deficiency in caspase-8,
its adaptor FADD, or caspase-8 activity enables formation of the
necroptosome complex containing RIPK1, RIPK3, and mixed lineage kinase domain-like (MLKL) upon stimulation by Toll-like receptors (TLRs) or tumor necrosis factor receptor (TNFR) (4–6).
Recently, caspase-8 activity was shown to be a determinant in the
switch to pyroptosis when apoptosis and necroptosis are inhibited
(7, 8). Expression of the protease-inactive form of caspase-8 triggered formation of apoptosis-associated speck-like protein containing a CARD (ASC) specks and subsequent caspase-1 activation.
Inflammasome assembly triggers proteolytic cleavage of
procaspase-1 into active caspase-1, which converts the cytokine
precursors pro–interleukin-1 (IL-1) and pro–IL-18 into mature and
biologically active IL-1 and IL-18 (9, 10). Active caspase-1 also induces
cleavage of gasdermin D (GSDMD) to execute pyroptosis (11–13).
The NLR family pyrin domain containing 3 (NLRP3) inflammasome
is the most well-characterized inflammasome type, and it is conventionally activated in two steps. The initial priming signal is triggered
by pattern recognition receptors, which induces nuclear factor 
(NF-) activation and downstream transcription of pro–IL-1 and
NLRP3. The subsequent activation signal provided by NLRP3 activators, such as pore-forming toxin or monosodium crystal, induces
a conformational change in NLRP3 and consequent recruitment of
ASC and caspase-1 to assemble the inflammasome complex. Caspase-8
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is known to participate in inflammasome activation for IL-1
production in several different ways. Ligation of TLR3 and TLR4
promotes caspase-8–mediated processing of pro–IL-1, which is
independent of NLRP3 and caspase-1 (14). Dectin-1 engagement
induces inflammasome activation, resulting in caspase-8–dependent
generation of active IL-1 (15). Depletion of inhibitors of apoptosis
protein (IAPs) by means of a second mitochondria-derived activator of caspases (SMAC) mimetic in TLR-primed myeloid cells
was found to trigger caspase-8–mediated generation of IL-1 (16).
Caspase-8 protease activity is essential in all of these inflammasome
activation processes, since inhibiting caspase-8 activity suppresses
the IL-1 generation in myeloid cells induced by TLR3, dectin-1,
SMAC mimetic, or FasL (14–16).
Both FADD and caspase-8 are involved in mediating the priming and activation of canonical and atypical NLRP3 inflammasomes,
as well as ASC oligomerization (17–22). Lipopolysaccharide (LPS)–
induced expression of pro–IL-1 or NLRP3 was previously shown
to be impeded in Casp8−/−Ripk3−/− and Fadd−/−Ripk3−/− macrophages (18, 21). NLRP3 activator–induced inflammasome activation could be blocked by using a caspase-8 inhibitor in LPS-primed
bone marrow–derived macrophages (BMDMs) (18). In contrast,
caspase-8 deficiency in dendritic cells was observed to facilitate
RIPK3-dependent LPS-induced assembly and the function of NLRP3
inflammasomes (23).
Autophagy is characterized by the cytosolic vacuole formed
upon initiation of the vacuolar membrane, autophagosome formation, and lysosome clearance of engulfed proteins, among other
processes (24). Excessive autophagosome formation leads to autophagic cell death, which is independent of other cell death processes, and it is suppressed by genetic inhibition of autophagy proteins
(25). Autophagy can regulate apoptosis and necroptosis, representing a type of “autophagy-dependent cell death.” Both caspase-8 and
FADD mediate autophagic cell death and autophagy-dependent
apoptosis. Knockdown of caspase-8 was shown to induce autophagic
cell death in a human cell line (26). Moreover, down-regulation of
FADD suppressed the cell death induced by the autophagy-associated
protein Atg5 (27). Autophagy and cell death are promoted in activated
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Caspase-8 activity controls the switch from cell death to pyroptosis when apoptosis and necroptosis are blocked,
yet how caspase-8 inactivation induces inflammasome assembly remains unclear. We show that caspase-8 inhibition via IETD treatment in Toll-like receptor (TLR)–primed Fadd−/−Ripk3−/− myeloid cells promoted interleukin-1
(IL-1) and IL-18 production through inflammasome activation. Caspase-8, caspase-1/11, and functional GSDMD,
but not NLRP3 or RIPK1 activity, proved essential for IETD-triggered inflammasome activation. Autophagy became prominent in IETD-treated Fadd−/−Ripk3−/− macrophages, and inhibiting it attenuated IETD-induced cell
death and IL-1/IL-18 production. In contrast, inhibiting GSDMD or autophagy did not prevent IETD-induced septic shock in Fadd−/−Ripk3−/− mice, implying distinct death processes in other cell types. Cathepsin-B contributes to
IETD-mediated inflammasome activation, as its inhibition or down-regulation limited IETD-elicited IL-1 production. Therefore, the autophagy and cathepsin-B axis represents one of the pathways leading to atypical inflammasome activation when apoptosis and necroptosis are suppressed and capase-8 is inhibited in myeloid cells.
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RESULTS

Caspase-8 inhibition elicits inflammasome activation
in Fadd−/−Ripk3−/− myeloid cells
To examine the process by which cell death switched to pyroptosis upon suppression of both apoptosis and necroptosis, we used
RIPK3-deficient mice (fig. S1, A to C) to generate Fadd−/−Ripk3−/−
mice. Knockout of FADD and RIPK3 in the Fadd−/−Ripk3−/−
BMDMs was confirmed by immunoblots (Fig. 1A). Caspase-8 is
known to mediate dectin-1–induced inflammasome activation (15).
First, we examined how dectin-1–mediated inflammasome activation was affected in Fadd−/−Ripk3−/− bone marrow–derived dendritic cells (BMDCs). Treatment with the dectin-1 agonists curdlan or
Zymosan Depleted (Dzymosan, which lacks TLR-stimulating properties) induced similar levels of IL-1 production in Fadd−/−Ripk3−/−
relative to Fadd+/−Ripk3−/− BMDCs (Fig. 1B). We then used z-IETDfmk (IETD), a known inhibitor of caspase-8 processing (fig. S1D),
to determine the effect of caspase-8 inactivation on this process. IL1 production in Fadd+/−Ripk3−/− BMDCs was suppressed by IETD
(Fig. 1B), confirming the requirement for caspase-8 protease activity in inflammasome activation (15). In contrast, IL-1 generation in Dzymosan-treated Fadd−/−Ripk3−/− cells was not affected
by IETD, whereas it was greatly enhanced by IETD in curdlan-treated
Fadd−/−Ripk3−/− cells (Fig. 1B), suggesting that caspase-8 inactivation
promotes inflammasome activation. Similarly, LPS alone did not
induce IL-1 generation in Fadd+/−Ripk3−/− or Fadd−/−Ripk3−/−
BMDCs, yet additional presence of IETD did stimulate IL-1 production in Fadd −/−Ripk3 −/− BMDCs (Fig. 1C). These results
indicate that in the absence of FADD and RIPK3, inhibition of
caspase-8 leads to TLR4- or dectin-1–mediated inflammasome activation in BMDCs.
We further examined the effect of IETD on cells stimulated with
another TLR agonist, R848, and found that a combination of R848
and IETD also induced IL-1 production in Fadd−/−Ripk3−/− cells
(Fig. 1C). Similar to BMDCs, IETD cotreatment with LPS or R848
induced IL-1 production in Fadd−/−Ripk3−/− BMDMs (Fig. 1D).
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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Since pro–IL-18 is constitutively expressed in BMDMs, we examined whether TLR agonists could induce high-level IL-18 secretion
in the presence of IETD in Fadd−/−Ripk3−/− BMDMs and found that
all TLR agonists we examined, including polyinosine-polycytidylic
acid (poly(I:C)), did so (Fig. 1E). Both IL-1 and IL-18 were detected 6
to 8 hours after LPS + IETD treatment in Fadd−/−Ripk3−/− BMDMs
(fig. S1E). To exclude the possibility that the observed effect was due
to incomplete inhibition of caspase-8, we applied IETD (10 M) repeatedly (four times) and found that IL-1 production and cell viability of Fadd−/−Ripk3−/− BMDMs and BMDCs were similar to values
determined following single-dose IETD administration (10 M)
(fig. S2, A to D). Moreover, we increased the dose of IETD from
10 to 40 M, and yet IL-1 production remained comparable in the
Fadd−/−Ripk3−/− BMDCs (fig. S2E). Application of the pan-caspase inhibitor QVD or zVAD at 40 M induced very low IL-1 production
(fig. S2E). These results illustrate that the amount of IETD we applied
was not a limiting factor for the biological effects we observed. We
also explored whether TLR signaling could be replaced by TNF stimulation but found that IETD and TNF cotreatment of Fadd−/−Ripk3−/−
BMDCs did not induce IL-1 production (Fig. 1F). Thus, the results
of our IETD treatment experiments suggest a scenario in myeloid
cells similar to previous reports demonstrating that caspase-8 inactivation promotes inflammasome activation upon blockade of apoptosis and necroptosis (7, 8).
Reduced TLR signaling in Fadd−/−Ripk3−/− myeloid cells
Our results show that impairment of caspase-8 protease activity
elicits TLR- or dectin-1–mediated inflammasome activation in
Fadd−/−Ripk3−/− myeloid cells. Next, we examined the expression of
inflammasome components during that process. Levels of procaspase-1,
ASC, and pro–IL-18 were comparable between wild-type (WT;
Fadd+/+Ripk3+/+), Fadd+/−Ripk3−/−, and Fadd−/−Ripk3−/− BMDMs
before and after IETD + LPS treatment (Fig. 2A). In contrast, expression levels of NLRP3 and pro–IL-1 were much lower in
Fadd−/−Ripk3−/− BMDMs than in WT or Fadd+/−Ripk3−/− BMDMs
after stimulation by IETD + LPS (Fig. 2A). Accordingly, induction
of IL-1 by IETD + LPS in Fadd−/−Ripk3−/− myeloid cells was not
due to higher expression of pro–IL-1 relative to that in FADDsufficient myeloid cells. We also detected a decreased level of TNF
induced by LPS or poly(I:C), but not R848, in Fadd−/−Ripk3−/−
BMDMs with or without IETD (fig. S3A). A similar reduction in
LPS-induced TNF was found in Fadd−/−Ripk3−/− BMDCs relative to
Fadd+/−Ripk3−/− BMDCs (fig. S3B). This outcome contrasts with
the normal TNF expression triggered by dectin-1 agonists in
Fadd−/−Ripk3−/− BMDCs (fig. S3C). The diminished induction of
NLRP3, pro–IL-1, and TNF was likely associated with attenuated
TLR activation in Fadd−/−Ripk3−/− BMDMs. LPS-induced NF-B
activation, marked by IKK [inhibitor of nuclear factor B (IB)
kinase] phosphorylation and IB degradation, was attenuated
in Fadd−/−Ripk3−/− relative to Fadd+/−Ripk3−/− BMDMs (Fig. 2B). A
more profound reduction in LPS-stimulated mitogen-activated
protein kinase (MAPK) signaling—as shown by decreased phosphorylation of c-Jun N-terminal kinase (JNK), p38, and extracellular
signal–regulated kinase (ERK)—was observed in Fadd−/−Ripk3−/−
BMDMs (Fig. 2C). Thus, deficiency in both FADD and RIPK3 impairs LPS-induced activation of NF-B and MAPK, consistent with
previous studies reporting that FADD and RIPK3 are required
for comprehensive innate signaling to prime inflammasome activation (17–21).
2 of 18
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T cells in the absence of FADD or caspase-8 signaling (28), with the
autophagosome membrane serving as a platform for caspase-8 and
FADD to mediate apoptosis (29). Therefore, capase-8 and FADD participate in autophagy-associated cell death in a stimulus- and cell
type–dependent manner.
In this study, we explored the biological processes involved in
inflammasome activation upon capase-8 inactivation in myeloid
cells when both apoptosis and necroptosis are suppressed. We used
LPS-stimulated FADD and RIPK3 double-knockout myeloid cells
(30) to demonstrate that inhibiting caspase-8 activity by means of
IETD induced IL-1 and IL-18 production. Atypical inflammasome
formation was characterized by ASC dimerization, and it was NLRP3
independent. In addition, autophagy/cathepsin-B preceded inflammasome formation and cell death, as autophagy/cathepsin-B
inhibition attenuated IL-1 production and cell death in the
Fadd−/−Ripk3−/− myeloid cells. In contrast, IETD-induced septic
shock in Fadd−/−Ripk3−/− mice was independent of autophagy,
cathepsin-B, caspase-1/11, and GSDMD, implying that distinct death
processes operate in other cell types. Therefore, here, we identify
autophagy/cathepsin-B as the cellular process specifically induced
by inactivated caspase-8 that partly accounts for inflammasome
activation and cell death in Fadd−/−Ripk3−/− myeloid cells.
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Recent studies suggested that inactive caspase-8 adopts a conformation distinct from active caspase-8, enabling the caspase-8 prodomain to nucleate ASC assembly for caspase-1 activation (7, 8).
We investigated whether IETD + R484 could induce ASC oligomerization in Fadd−/−Ripk3−/− BMDCs, given that IETD + R484 treatment triggered a higher level of IL-1 production than observed for
IETD + LPS treatment (Fig. 1C). First, R848 + nigericin treatment,
which triggers canonical NLRP3 inflammasome formation, induced
ASC dimer and oligomer formation in Fadd+/−Ripk3−/− BMDCs
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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(Fig. 2D), whereas weaker ASC dimer formation was detected in
Fadd−/−Ripk3−/− BMDCs subjected to the same treatment (Fig. 2D),
likely attributable to the attenuated induction of NLRP3 by TLR
(Fig. 2A). Consistent with that finding, the generation of p20 caspase-1
and p17 IL-1 was lower in Fadd−/−Ripk3−/− BMDCs than in
Fadd+/−Ripk3−/− BMDCs when stimulated by LPS + nigericin (Fig. 2E,
L + N). In contrast, no ASC dimer was detected in Fadd+/−Ripk3−/−
BMDCs stimulated by IETD + R484, whereas IETD + R484 induced dimerization of ASC in Fadd−/−Ripk3−/− BMDCs (Fig. 2D).
3 of 18
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Fig. 1. Caspase-8 inhibition elicits TLR-mediated inflammasome activation in Fadd−/−Ripk3−/− myeloid cells. (A) Expression of FADD and RIPK3 in Fadd+/+Ripk3+/+,
Fadd+/−Ripk3−/−, and Fadd−/−Ripk3−/− BMDMs, as determined by Western blot. (B) IETD induces IL-1 production in Fadd−/−Ripk3−/− BMDCs stimulated with dectin-1 agonists. BMDCs were stimulated with curdlan (20 g/ml) or Dzymosan (50 g/ml), in the absence or presence of IETD (20 M) for 8 hours, before analyzing IL-1 levels in
culture supernatant by ELISA. Data are means ± SD of technical triplicates from one experiment and are representative of three independent experiments. (C) IETD + TLR
agonists induce IL-1 production in Fadd−/−Ripk3−/− BMDCs. BMDCs were stimulated with LPS (0.1 g/ml) or R848 (1 g/ml) in the presence or absence of IETD (20 M) for
20 hours, and IL-1 levels were then determined. Data are means of three independent experiments. (D and E) IETD + TLR agonists induce IL-1 and IL-18 production in
BMDMs. BMDMs were stimulated with LPS (0.1 g/ml), R848 (1 g/ml), or poly(I:C) (50 g/ml) in the presence or absence of IETD (10 M) for 20 hours, and then IL-1 (D)
and IL-18 (E) production was determined. Data are means of three independent experiments. (F) IETD does not induce IL-1 production in TNF-stimulated Fadd−/−Ripk3−/−
BMDCs. BMDCs were stimulated with LPS (0.1 g/ml) or TNF (50 ng/ml) in the presence or absence of IETD for 8 hours, and then IL-1 production was quantitated.
*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 for two-way ANOVA followed by Si’ak's multiple comparisons test.
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The formation of ASC specks is in agreement with the appearance of p20 caspase-1 and p17 IL-1 in Fadd−/−Ripk3−/− BMDCs,
but not in Fadd+/−Ripk3−/− BMDCs treated with LPS + IETD
(Fig. 2E, L + I). We found that production of IL-1 was lower in
Fadd−/−Ripk3−/− BMDMs than in Fadd−/−Ripk3−/− BMDCs, but activation of caspase-1 and cleavage of pro–IL-18 were also apparent
in Fadd−/−Ripk3−/− BMDMs (Fig. 2F, L + I). Therefore, IETD plus
a TLR agonist can trigger assembly of ASC into inflammasomes
in Fadd −/−Ripk3 −/− myeloid cells, leading to the processing of
procaspase-1 and generation of mature IL-1/IL-18.
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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Requirement of caspase-8 and caspase-1/11 for IETDinduced inflammasome activation in Fadd−/−Ripk3−/− cells
We found that inclusion of the pan-caspase inhibitor z-VAD-fmk
with LPS, R848, or pIC induced very low levels of IL-1 or IL-18
production in Fadd−/−Ripk3−/− BMDMs and BMDCs (fig. S2E and
Fig. 3A), implying a requirement for other caspase(s) in atypical
generation of those interleukins. Next, we delineated the requirement for caspase-8 in LPS/R848 + IETD–induced IL-1 production. Unlike for caspase-8 inactivation, knockdown of caspase-8
failed to trigger IL-1 secretion in LPS-treated Fadd−/−Ripk3−/− or
4 of 18
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Fig. 2. Attenuated TLR signaling in Fadd−/−Ripk3−/− myeloid cells. (A) Fadd−/−Ripk3−/− BMDMs were stimulated with LPS (0.1 g/ml) plus IETD (10 M) for 4 hours, and
levels of NLRP3, procaspase-1, ASC, and pro–IL-1 in cell lysates were then determined by immunoblotting. (B and C) Attenuated TLR activation signals in Fadd−/−Ripk3−/−
BMDMs. Fadd−/−Ripk3−/− BMDMs were stimulated with LPS (0.1 g/ml) for the indicated time frames. Cell lysates were then analyzed for p-IKK, IKK, and IB (B) and p-JNK,
JNK, p-p38, p38, p-ERK, and ERK (C). (D) Formation of ASC pyroptosomes. BMDMs were stimulated with R848 (1 g/ml) plus nigericin (N; 15 M) or R848 (1 g/ml) plus IETD
(I; 10 M). Total cell lysates were cross-linked by dextran sulfate sodium (DSS) and immunoblotted with anti-ASC. (E) BMDCs were stimulated with LPS (0.1 g/ml) plus
IETD (10 M) for 6 hours (L + I) or LPS for 2 hours followed by nigericin (15 M) for 20 min (L + N). Culture supernatants (SUP) were precipitated, and whole-cell lysates
(WCL) were collected and analyzed for cleavage of procaspase-1 and pro–IL-1. (F) BMDMs were stimulated with LPS (0.1 g/ml) plus IETD (10 M) for 10 hours (L + I) or
LPS for 2 hours followed by nigericin (15 M) for 20 min (L + N). Culture supernatants (SUP) were precipitated, and whole-cell lysates (WCL) were collected and analyzed
for cleavage of procaspase-1, pro–IL-18, and GSDMD. Results are representative of two (B to D) or three (A, E, and F) independent experiments.
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Fadd+/−Ripk3−/− BMDCs (Fig. 3B). Instead, knockdown of caspase-8
specifically inhibited LPS + IETD–induced IL-1 production in
Fadd−/−Ripk3−/− BMDCs (Fig. 3B), further evidencing the essentiality of caspase-8 in inflammasome activation. Therefore, specific inactivation of caspase-8 activity, while ensuring the respective protein
remains intact, is responsible for IL-1 production in Fadd−/−Ripk3−/−
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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myeloid cells. We also determined whether IL-1 could be induced
in the presence of RIPK3 by using Fadd−/−FADD:GFPfLyzM-Cre
BMDMs (fig. S4A) and found that LPS alone induced IL-1 production in RIPK3-sufficient and FADD-deficient BMDMs, but it
was completely blocked upon IETD treatment (fig. S4B), further
supporting a requirement for caspase-8 activity. These results suggest
5 of 18
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Fig. 3. Caspase-8 and caspase-1/11 are required for IETD-induced IL-1/IL-18 production in Fadd−/−Ripk3−/− myeloid cells. (A) BMDMs were stimulated with LPS
(0.1 g/ml), R848 (1 g/ml), or poly(I:C) (50 g/ml), without or with IETD (10 M) or zVAD (40 M) for 18 hours, before quantitating IL-1. (B) BMDCs were transfected with
control or caspase-8 siRNA for 24 hours. Caspase-8 was assessed by immunoblotting (upper panel). BMDCs were then treated with LPS plus IETD for 8 hours, before determining IL-1 production (lower panel). Data are means ± SD of three independent experiments. (C and D) BMDCs (C) or BMDMs (D) were stimulated with LPS, R848,
Dzymosan (50 g/ml), poly(I:C), IETD, YVAD (20 M), or Nec-1 (40 M), as indicated, for 8 hours (C) or 18 hours (D), before analyzing production of IL-1 (C) and IL-18 (D).
(E) Levels of caspase-1, caspase-11, and FADD in BMDCs of indicated casp1/11 genotypes. (F) IL-1 production by BMDCs of indicated genotypes treated with LPS plus
IETD or LPS followed by nigericin. (G and H) BMDCs (G) and BMDMs (H) were treated with LPS plus IETD (L + I) for 6 hours (G) or 10 hours (H) or LPS for 2 hours followed
by nigericin (15 M) for 20 min (L + N). Culture supernatants and whole-cell lysates were analyzed for specific protein cleavage. Results (G and H) are representative of
three independent experiments. Data are means ± SD of technical triplicates from one experiment and are representative of three independent experiments (A, C, D, and
F). ****P < 0.0001 for two-way ANOVA followed by Sidak's multiple comparisons test (B and F).
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Involvement of GSDMD in IETD-induced IL-1 secretion
in Fadd−/−Ripk3−/− myeloid cells
Inflammasome activation leads to active caspase-1 being generated,
which in turns cleaves GSDMD, enabling oligomerization of the
N-terminal part of GSDMD (GSDMD-NT) to form pores in cell
membrane. GSDMD-mediated pore formation leads to cell lysis and
pyroptotic death (12, 13). GSDMD pores also facilitate transportation of active IL-1 and IL-18 across intact membrane and their release from live cells (12, 31). In contrast to the prominent GSDMD
cleavage induced by canonical inflammasomes detected in both cell
lysates and culture supernatants, processing of GSDMD-NT could
be detected mainly in supernatants from Fadd−/−Ripk3−/− BMDCs
(Figs. 2F, 3, G and H, and 4A). The generation of GSDMD-NT was
blocked in Casp1/11−/− BMDCs and BMDMs (Fig. 3, G and H), suggesting that caspase-1/11 operates upstream of GSDMD cleavage.
To further investigate whether the lack of active IL-1 secretion in
Fadd−/−Ripk3−/−Casp1/11−/− myeloid cells was associated with the
lack of N-GSDMD pore formation, we examined the impact of
GSDMD by using disulfiram, which specifically inhibits GSDMD
pore formation (32). Disulfiram at a concentration that does not
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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trigger cell death (2.5 M) attenuated the generation of IL-1 and
IL-18 induced by LPS + IETD in Fadd−/−Ripk3−/− myeloid cells
(Fig. 4, B and C). We further generated control and Fadd−/−Ripk3−/−
mice with additional knockout of GSDMD (Fig. 4D). GSDMD knockout
suppressed IETD-triggered IL-1 production in Fadd−/−Ripk3−/−
BMDCs (Fig. 4E). As a control, GSDMD deficiency impaired the
IL-1 secretion induced by a canonical inflammasome-activating
treatment (LPS + nigericin) in Fadd+/−Ripk3+/+ and Fadd−/−Ripk3−/−
BMDCs (Fig. 4F). These results provide evidence that GSDMD is
involved in the release of IL-1 and IL-18 that is induced upon
caspase-8 inactivation and is activated by caspase-1/11 cleavage in
Fadd−/−Ripk3−/− myeloid cells.
Caspase-8 has been reported to regulate NLRP3-dependent and
NLRP3-independent inflammasome activation. We also determined
the role of NLRP3 in LPS-induced caspase-8–mediated inflammasome
activation in Fadd−/−Ripk3−/− cells. NLRP3 knockout blocked the
IL-1 secretion induced by canonical NLRP3 inflammasome activator LPS + nigericin in Fadd−/−Ripk3−/− BMDMs and BMDCs (fig. S7A).
However, NLRP3 deficiency did not prevent production of IL-1 and
IL-18 in LPS + IETD–treated Fadd−/−Ripk3−/− BMDMs (fig. S7B) or
BMDCs (fig. S7C). Moreover, NLRP3 knockout did not affect levels
of IL-1 and IL-18 in Fadd−/−Ripk3−/− myeloid cells stimulated with
R848 + IETD or CpG + IETD (fig. S7, B and C). Therefore, NLRP3
is dispensable for IETD-induced TLR-dependent atypical inflammasome activation.
IETD induces cell death in Fadd−/−Ripk3−/− myeloid cells
As expected from FADD and RIPK3 deficiency, Fadd−/−Ripk3−/−
cells were fully resistant to apoptotic and necroptotic death (fig. S8,
A and B). We found that LPS/pIC + IETD treatment elicited profound cell death in Fadd−/−Ripk3−/− myeloid cells (Fig. 5A and fig.
S8C), a phenomenon not recapitulated by LPS + zVAD (Fig. 5B).
Fadd−/−Ripk3−/− BMDCs were also susceptible to cell death induced
by R848/Dzymosan + IETD treatments (fig. S8D). The vulnerability
to LPS + IETD stimulation was observed mainly in myeloid cells, as
Fadd−/−Ripk3−/− mouse embryonic fibroblasts were fully resistant to the
same treatment (fig. S8E). We detected multiple vesicular structures inside abundant dying Fadd−/−Ripk3−/− BMDMs treated with LPS + IETD
(Fig. 5C), as revealed by propidium iodide (PI) staining (33) (Fig. 5D).
We further elucidated the components required for IETD-
induced cell death in Fadd−/−Ripk3−/− myeloid cells. Caspase-8 knockdown restored the viability of IETD-treated Fadd−/−Ripk3−/− myeloid
cells (Fig. 5E), indicating that the physical presence of caspase-8 is
indispensable. Just as GSDMD-knockout suppressed IL-1 generation in Fadd−/−Ripk3−/− BMDMs and BMDCs (Fig. 4, A and B),
GSDMD deficiency also abrogated cell death triggered by either canonical inflammasome activation or LPS + IETD (Fig. 5, F and G).
In contrast, neither YVAD nor Nec-1 prevented IETD-triggered
death in Fadd−/−Ripk3−/− myeloid cells (Fig. 5H). Deficiency in both
caspase-1 and caspase-11 also suppressed IETD-mediated death in
Fadd−/−Ripk3−/− BMDCs (Fig. 5I). Thus, similar involvement of intact caspase-8, caspase-1/11, and GSDMD in the generation of IL1/IL-18 and cell death in Fadd−/−Ripk3−/− myeloid cells implies that
the cell death is a consequence of atypical inflammasome activation.
IETD-induced septic shock in Fadd−/−Ripk3−/− mice
We also determined the systemic impact of IETD-induced cell
death. Intraperitoneal administration of IETD did not affect survival
of control Fadd+/−Ripk3−/− mice, but it was extensively fatal in
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that in the absence of FADD, TLR signaling alone can induce
caspase-8– and RIPK3-dependent inflammasome activation. However, in the absence of both FADD and RIPK3, specific inhibition
of caspase-8 activity can still ensure inflammasome activation in the
presence of TLR priming signaling.
Another irregularity we observed in our Fadd−/−Ripk3−/− BMDMs
was a reduction in RIPK1 protein expression (fig. S5A), despite Ripk1
mRNA levels being comparable between Fadd +/−Ripk3 −/− and
Fadd−/−Ripk3−/− BMDMs (fig. S5B). We examined whether the protease inhibitor MG132, the lysosome fusion inhibitors chloroquine
and ammonium chloride, or the RIPK1 kinase inhibitor necrostatin-1
(Nec-1) could restore protein levels of RIPK1 in Fadd−/−Ripk3−/−
BMDMs. However, with the exception of Nec-1, none of those inhibitors rescued RIPK1 expression levels in Fadd−/−Ripk3−/− BMDMs
(fig. S5C), implying that RIPK1 down-regulation is dependent on
RIPK1 kinase activity.
Moreover, we used the caspase-1 inhibitor YVAD and Nec-1 to
determine whether caspase-1 or RIPK1 activity is required for TLR/
dectin-1 + IETD–induced IL-1 production in Fadd−/−Ripk3−/−
myeloid cells. Neither YVAD nor Nec-1 effectively interfered with
the IL-1 and IL-18 production induced by TLR/dectin-1 + IETD in
Fadd−/−Ripk3−/− myeloid cells (Fig. 3, C and D). YVAD treatment,
the efficacy of which was verified by almost complete suppression of
canonical inflammasome-mediated generation of p20 caspase-1 and
p17 IL-1 in BMDCs (fig. S6, L + N), was unable to inhibit LPS +
IETD–induced processing of caspase-1 and IL-1 in Fadd−/−Ripk3−/−
BMDCs (fig. S6, L + I). These results indicate that caspase-1 and
RIPK1 activity is not essential for IETD + LPS–triggered atypical
inflammasome formation in Fadd−/−Ripk3−/− myeloid cells. We further
introduced casp1/11−/− into the respective myeloid cells (Fig. 3E).
Knockout of caspase-1/11 eliminated IL-1 generation induced
by LPS + nigericin in Fadd+/−Ripk3−/− and Fadd−/−Ripk3−/− BMDCs,
as revealed by both enzyme-linked immunosorbent assay (ELISA)
and immunoblots (Fig. 3, F and G, L + N). Caspase-1/11 deficiency abrogated IL-1 secretion triggered by LPS + IETD in
Fadd−/−Ripk3−/− BMDCs (Fig. 3, F and G, L + I). Therefore, the
presence of caspase-1/11 is required for the generation of p17 IL-1
in Fadd−/−Ripk3−/− myeloid cells.
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Fadd−/−Ripk3−/− mice (Fig. 6A). We also observed elevated serum
levels of IL-6 in Fadd−/−Ripk3−/− mice 3 hours after IETD administration (Fig. 6B). We conducted peritoneal lavage of the mice to
assess cell viability and cytokine levels. Fadd−/−Ripk3−/− mice treated
with IETD exhibited reduced peritoneal cell viability relative to control mice (Fig. 6C), as well as elevated expression of IL-1 and IL-6
(Fig. 6D). We also determined whether NLRP3 is required for IETDinduced septic shock in Fadd−/−Ripk3−/− mice. NLRP3 knockout did not
rescue Fadd−/−Ripk3−/− mice from IETD-induced mortality (Fig. 6E).
Consistent with this sensitivity to IETD, levels of IL-6 were higher in
peritoneal cells isolated from IETD-primed Fadd−/−Ripk3−/−Nlrp3−/−
mice compared to IETD-primed Fadd−/−Ripk3−/−Nlrp3+/+ mice (Fig. 6F).
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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Similar to IETD-induced inflammasome activation in Fadd−/−Ripk3−/−
myeloid cells, IETD induced septic shock in Fadd−/−Ripk3−/− mice
independently of NLRP3. Emricasan, a caspase inhibitor that also
suppresses caspase-8, displayed a similar effect as IETD in terms of
inducing septic shock in Fadd−/−Ripk3−/− mice (Fig. 6G).
Autophagy mediates IETD-induced inflammasome
activation in Fadd−/−Ripk3−/− myeloid cells
We had observed that LPS + IETD treatment induced the appearance of small spherical vesicles in the cytosol of Fadd−/−Ripk3−/−
BMDMs (Fig. 5C), so we investigated the possibility that autophagy
had been triggered. We found that the autophagy-specific inhibitor
7 of 18
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Fig. 4. Involvement of GSDMD in IL-1/IL-18 production in IETD-treated Fadd−/−Ripk3−/− myeloid cells. (A) BMDCs were treated with LPS plus IETD for 6 hours (L + I)
or LPS for 2 hours followed by nigericin for 20 min (L + N). Culture supernatants and whole-cell lysates were collected and analyzed for cleavage of GSDMD. Short exp,
1-min exposure; Long exp, 3-min exposure. (B and C) Fadd−/−Ripk3−/− BMDMs (B) and BMDCs (C) were treated with LPS (0.1 g/ml) + IETD (10 M) in the absence or presence of disulfiram (2.5 M) for 16 hours before determining IL-1 (B and C) and IL-18 (B) production. (D) GSDMD, RIPK3, and FADD contents in Fadd+/−Ripk3+/+Gsdmd+/−,
Fadd−/−Ripk3−/− Gsdmd−/−, Fadd−/−Ripk3−/−Gsdmd+/+, and Fadd−/−Ripk3−/−Gsdmd−/− BMDCs. (E) IL-1 production by Fadd+/−Ripk3+/+Gsdmd+/−, Fadd−/−Ripk3−/−Gsdmd−/−,
Fadd−/−Ripk3−/−Gsdmd+/+, and Fadd−/−Ripk3−/−Gsdmd−/− BMDCs treated with LPS + IETD for 16 hours. (F) IL-1 production by Fadd+/−Ripk3+/+Gsdmd+/−, Fadd−/−Ripk3−/−Gsdmd−/−,
Fadd−/−Ripk3−/−Gsdmd+/+, and Fadd−/−Ripk3−/−Gsdmd−/− BMDCs treated with LPS (0.1 g/ml) for 3 hours followed by nigericin (20 M) for 1 hour. Data (B, C, E, and F) are
means of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 for two-way ANOVA followed by Sidak's multiple comparisons test.
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3-methyladenine (3-MA) suppressed LPS + IETD–induced cell death
in Fadd−/−Ripk3−/− myeloid cells (Fig. 7, A and B). Next, we used
the autophagy-specific fluorescence dye DAPGreen to characterize
LPS + IETD–induced cell death. DAPGreen signal was absent from
Fadd−/−Ripk3−/− BMDMs stimulated with LPS alone but became
abundant upon LPS + IETD treatment (Fig. 7C). Moreover, intracellular vesicles colocalized with DAPGreen signal in dying Fadd−/−Ripk3−/−
BMDMs (Fig. 7C). In contrast, we did not detect DAPGreen signals
upon treatment with other stimuli, including necroptosis induction
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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(LPS + zVAD), canonical inflammasome activation (LPS + nigericin),
and intrinsic apoptosis (dexamethasone) (fig. S9), evidencing the specificity of DAPGreen signal. For LPS + IETD–treated Fadd−/−Ripk3−/−
BMDMs monitored under time-lapse fluorescence microscopy, the
appearance of DAPGreen signal was immediately followed by PI+ signal (movies S1 and S2). 3-MA significantly inhibited the DAPGreen
signals induced by LPS + IETD in Fadd−/−Ripk3−/− BMDMs (Fig. 7D),
revealing that deficiency of both FADD and RIPK3 leads to autophagy-
dependent cell death upon stimulation with LPS + IETD.
8 of 18
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Fig. 5. IETD induces caspase-8–, caspase-1/11–, and GSDMD-dependent cell death in Fadd−/−Ripk3−/− myeloid cells. (A) BMDMs were stimulated with LPS (0.1 g/ml)
or poly(I:C) (50 g/ml) plus IETD (10 M) for 20 hours. LDH release and cell viability (determined by ATP assay) were analyzed. (B) BMDMs were stimulated with LPS
plus IETD or zVAD (40 M) for 16 hours, and cell viability was analyzed. (C and D) BMDMs were stimulated with LPS with or without IETD, in the absence (C) or presence of
PI (D), for 16 hours. Scale bars, 25 m (C) and 50 m (D). Bright-field images are representative of three independent experiments. (E) Fadd−/−Ripk3−/− BMDCs were transfected with control or caspase-8 siRNA for 24 hours, followed by LPS + IETD treatment for 8 hours, and LDH release was determined. (F and G) LDH release from BMDCs of
indicated Gsdmd genotypes upon treatment with LPS + nigericin for 20 min (F) or with LPS + IETD for 8 hours (G). (H) Fadd−/−Ripk3−/− BMDCs and BMDMs were stimulated
with LPS + IETD without or with YVAD (20 M) or Nec-1 (40 M) for 18 hours, and then LDH release was determined. (I) BMDCs of indicated Casp1/11 genotypes were
treated with LPS or LPS + IETD for 7.5 hours, and LDH release was quantified. Data represent four (A), five (E), and three (F to H) independent experiments, and mean values
are indicated. For (B) and (I), data represent means ± SD of technical triplicates of an experiment representative of three independent experiments. *P < 0.05, **P < 0.01,
***P < 0.001, and ****P < 0.0001 for two-way ANOVA followed by Sidak's multiple comparisons test. ns, not significant.

SCIENCE ADVANCES | RESEARCH ARTICLE

Our results illustrated in Fig. 7 demonstrate that 3-MA inhibited
LPS + IETD–induced cell death in Fadd−/−Ripk3−/− myeloid cells.
Autophagy involves fusion of autophagosomes with lysosomes, followed by excessive autolysosome formation. We examined whether
the lysosome fusion inhibitor chloroquine or ammonium chloride blocked inflammasome activation as effectively as 3-MA in
Fadd−/−Ripk3−/− BMDMs. Similar to 3-MA, both chloroquine and
ammonium chloride inhibited LPS + IETD–induced IL-1 or IL-18
production by Fadd−/−Ripk3−/− BMDMs and BMDCs (Fig. 8, A
and B). Both lysosome fusion inhibitors also inhibited LPS + IETD–
induced cell death (Fig. 8C). A recent study has shown that histone
deacetylase 6 (HDAC6) and microtubule assembly are required for
NLRP3 inflammasome activation (34). Accordingly, we assessed
whether the HDAC6 inhibitor tubacin or the tubulin polymerization inhibitor colchicine affected LPS + IETD–induced IL-18 production and cell death. However, neither tubacin nor colchicine
had an impact on either parameter (fig. S10, A and B). 3-MA inhibited the generation of p20 caspase-1, p17 IL-1, and GSDMD-NT
induced by LPS + IETD in Fadd−/−Ripk3−/− BMDCs, although 3-MA
treatment modestly enhanced the expression of pro–IL-1 (Fig.
8D). LPS + IETD treatment also induced cleavage of caspase-3 in
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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Fadd−/−Ripk3−/− BMDMs (Fig. 8E), similar to observations in MLKLdeficient mice expressing inactive caspase-8 (7), and caspase-3 processing was inhibited by 3-MA (Fig. 8E). Notably, the caspase-3
inhibitor DEVD did not interfere with the IL-18 production and
cell death induced by LPS + IETD (fig. S10, C and D). Neither did
knockdown of caspase-3 nor caspase-7 affect inflammasome activation and cell death triggered by LPS + IETD (fig. S10E). We further
knocked down Atg-5 in Fadd−/−Ripk3−/− BMDCs and observed a reduction in IETD-triggered IL-1 production (Fig. 8, F and G). Atg-5 downregulation also reduced IETD-induced cell death in Fadd−/−Ripk3−/−
BMDCs (Fig. 8G). Similarly, Beclin-1 knockout in Fadd−/−Ripk3−/−
BMDMs (Fig. 8H) reduced IETD-triggered IL-1 production and partially
rescued Fadd−/−Ripk3−/− BMDMs from IETD-induced cell death
(Fig. 8I). Together, these results indicate that caspase-8 inactivation
induces autophagy- and ASC-dependent, yet NLRP3-independent,
inflammasome activation in Fadd−/−Ripk3−/− myeloid cells.
IETD-induced septic shock in Fadd−/−Ripk3−/− mice is
independent of GSDMD and autophagy
We then examined whether IETD-induced septic shock involved
IL-1/IL-18, caspase-1/11, GSDMD, or autophagy. Administration
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Fig. 6. IETD induces NLRP3-independent septic shock in Fadd−/−Ripk3−/− mice. (A) Age- and sex-matched Fadd+/−Ripk3−/− and Fadd−/−Ripk3−/− mice were intraperitoneally injected with IETD (5 mg/kg), and then survival was determined at the indicated time points. The P value was determined by a log-rank (Mantel-Cox) test. (B) Serum
concentration of IL-6 in mice before and 3 hours after IETD administration. n = 3 (control) and n = 6 (IETD). (C) Peritoneal cells were isolated from mice 3 hours after PBS or
IETD administration. Viability was assessed by means of PI staining and quantitated by flow cytometry. Data are mean values for the PBS group (n = 3) or IETD group (n = 6).
(D) Peritoneal cells were isolated from mice 3 hours after PBS or IETD administration, before determining levels of IL-6 and IL-1. Data are mean values from n = 3 (PBS)
and n = 6 (IETD). (E) Fadd+/−Ripk3−/−Nlrp3−/− and Fadd−/−Ripk3−/−Nlrp3−/− mice were administered with IETD (5 mg/kg) before determining survival (n = 7 for each group).
The P value was determined by a log-rank (Mantel Cox) test. (F) Peritoneal cells were isolated from mice 3 hours after PBS or IETD administration, and then their production of IL-6 was determined (n = 3 for each group). (G) Emricasan (20 mg/kg) was administered to Fadd+/−Ripk3−/− (n = 7) and Fadd−/−Ripk3−/− (n = 6) mice, before determining mouse survival. The P value was determined by a log-rank (Mantel-Cox) test. (B to D and F) *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 for two-way
ANOVA followed by a Sidak’s multiple comparison test.
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of anti–IL-1 and anti–IL-18 did not prevent the lethality of
Fadd−/−Ripk3−/− mice induced by IETD (fig. S11A), and application
of disulfiram had no effect on the IETD-induced septic shock displayed by Fadd−/−Ripk3−/− mice (fig. S11B). In addition, deletion of
caspase-1 and caspase-11 failed to rescue Fadd−/−Ripk3−/− mice
from IETD-induced death (fig. S11C). GSDMD knockout also did
not prevent Fadd−/−Ripk3−/− mice from IETD-mediated death (fig.
S11D). Neither did inhibition of autophagy by 3-MA confer resistance to IETD on Fadd−/−Ripk3−/− mice (fig. S11E). Since systemic
Beclin-1 deletion is embryonically lethal, we used Fadd−/−Ripk3−/−
Becn1f/fLysMCre mice to determine their susceptibility to IETD. Beclin-1
deficiency in myeloid cells did not prevent IETD-triggered septic shock
in Fadd−/−Ripk3−/− mice (fig. S11F). Therefore, the processes involved
in IETD-induced inflammasome activation in Fadd−/−Ripk3−/− myeloid cells alone cannot account for the systemically lethal effect of
IETD in Fadd−/−Ripk3−/− mice. Although caspase-1/11, autophagy, and
GSDMD mediate pyroptosis in IETD-stimulated Fadd−/−Ripk3−/−
myeloid cells, they are likely dispensable for the death of other cell
types in IETD-treated Fadd−/−Ripk3−/− mice.
One cell type potentially vulnerable to caspase-8 inactivation is
intestinal epithelial cells (IECs) (7, 8), so we determined the effect of
IETD on those cells. Stimulation with LPS + IETD led to elevated
cell death in Fadd−/−Ripk3−/− IECs (fig. S12A). Moreover, treatment
of Fadd−/−Ripk3−/− IECs with zVAD or 3-MA did not prevent
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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IETD-induced cell death (fig. S12B), suggesting that IECs are distinct from myeloid cells in terms of the involvement of autophagy
in inflammasome activation following IETD treatment.
Cathepsin-B mediates IETD-induced inflammasome
activation in Fadd−/−Ripk3−/− myeloid cells
Although we found that IETD induced autophagy and inflammasomeassociated pyroptosis in Fadd−/−Ripk3−/− myeloid cells, the exact identities of the intermediate caspases/proteases activated by IETD
remained obscure. Thus, first, we determined whether inhibition of
other caspases mimicked the effect of IETD on Fadd−/−Ripk3−/− myeloid cells. To do so, Fadd−/−Ripk3−/− macrophages were stimulated
with LPS plus various caspase inhibitors. In contrast to IETD, caspase
inhibitors including VDVAD, VX-765, QVD, and zVAD all failed
to stimulate IL-1 expression and induce cell death in LPS-primed
Fadd−/−Ripk3−/− BMDCs (fig. S13, A and B). Therefore, inhibition of
other caspase did not reproduce the effect of IETD on Fadd−/−Ripk3−/−
myeloid cells.
Notably, pan-caspase inhibitor zVAD and QVD did not trigger
inflammasome activation and cell death despite suppression of
caspase-8 in Fadd−/−Ripk3−/− myeloid cells, suggesting that inhibition of caspase-8 by IETD induces another caspase/protease that is
also suppressed by zVAD or QVD. This scenario was also illustrated
by the IL-1 production and cell death induced by LPS + IETD
10 of 18
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Fig. 7. Involvement of autophagy in IETD-induced cell death in Fadd−/−Ripk3−/− myeloid cells. (A) Bright-field and PI staining images of BMDMs stimulated by
LPS + IETD in the presence of 3-MA. Fadd−/−Ripk3−/− BMDMs were treated with LPS (0.1 g/ml) + IETD (10 M) in the absence or presence of 3-MA (1 mM) for 18 hours.
Images are representative of three independent experiments. Scale bar, 50 m. (B) 3-MA inhibits IETD-induced cell death in Fadd−/−Ripk3−/− myeloid cells. Fadd−/−Ripk3−/−
BMDCs and BMDMs were stimulated with LPS + IETD in the absence or presence of 3-MA (1 mM) for 8 hours (BMDCs) or 18 hours (BMDMs), and then LDH release was
determined. LDH released from Ctrl cells treated with LPS + IETD was set as 1. Data represent mean values of four independent experiments. (C) Immunofluorescence
analysis of DAPGreen in Fadd−/−Ripk3−/− BMDMs. BMDMs were stained with DAPGreen (0.2 M) for 30 min and then stimulated with LPS (0.1 g/ml) plus IETD (10 M) for
16 hours. Cell nuclei were stained with Hoechst 33342 Ready Flow reagent. Scale bar, 25 m. Images are representative of four independent experiments. Average DAPGreen fluorescence intensity in a cell was quantified in ImageJ. The fluorescence intensity induced by LPS + IETD was compared to that of LPS alone. (D) 3-MA inhibits
IETD-induced autophagy in Fadd−/−Ripk3−/− BMDMs. Fadd−/−Ripk3−/− BMDMs were stained with DAPGreen and stimulated with LPS + IETD as in (C), in the absence or
presence of 3-MA (1 mM) for 16 hours. Images are representative of four independent experiments. Scale bar, 50 m. Images were quantified as in (C). *P < 0.05, **P < 0.01,
and ****P < 0.0001 for two-way ANOVA followed by Sidak's (B) or Tukey’s (C and D) multiple comparisons test.
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Fig. 8. Inhibition of autophagy attenuates IETD-induced inflammasome activation in Fadd−/−Ripk3−/− myeloid cells. (A to C) Fadd−/−Ripk3−/− BMDMs (A) and BMDCs
(B and C) were stimulated with LPS (0.1 g/ml) plus IETD (10 M) in the absence (Ctrl) or presence of 3-MA (1 mM), chloroquine (10 M), or NH4Cl (2 mM) for 18 hours (A)
or 8 hours (B and C); then IL-1 (A, B) and IL-18 (A) levels were determined; and LDH release (C) was quantitated. (D and E) Fadd−/−Ripk3−/− BMDCs were treated with LPS,
IETD, or 3-MA as indicated. Culture supernatants (D) and whole-cell lysates (D and E) were analyzed for inflammasome effectors. Results are representative of three independent experiments. (F and G) Fadd−/−Ripk3−/− BMDCs were transfected with control or Atg-5–specific siRNAs for 24 hours, and then Atg5 contents were determined (F).
Cells were then treated with LPS + IETD for 8 hours, before determining IL-1 production (G, left panel) and LDH release (G, right panel). (H) Beclin-1, RIPK3, and FADD
contents in BMDMs of indicated Becn1 genotypes were determined. (I) BMDMs were treated with LPS (0.1 g/ml) + IETD (10 M) for 18 hours, and then IL-1 levels were
determined by ELISA (upper panel). LDH release was quantitated (lower panel). Data represent three [A, B, G (LDH), and I] or four [C and G (IL-1)] independent experiments, and mean values are indicated. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 for two-way ANOVA followed by a Sidak’s multiple comparison test.
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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DISCUSSION

Caspase-8 is well known for its various roles in controlling apoptosis, necroptosis, and pyroptosis. In this study, we uncovered an
unconventional function for caspase-8 in mediating inflammasome
activation and cell death in myeloid cells deficient in both FADD and
RIPK3. Administration of IETD into the peritoneum of Fadd−/−Ripk3−/−
mice resulted in inflammatory cytokine production and mortality
within hours. We have further identified that IETD could trigger
autophagy in Fadd−/−Ripk3−/− myeloid cells. Inhibition of autophagy partially suppressed IETD-induced IL-1/IL-18 production and
cell death in these cells. Suppression of cathepsin-B also inhibited
Wu et al., Sci. Adv. 8, eabn9912 (2022)
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IETD-triggered inflammasome activation in Fadd−/−Ripk3−/− myeloid cells. Our results suggest that autophagy and cathepsin-B
activity represent intermediate steps between the caspase-8 inactivation, inflammasome formation, and cell death in myeloid cells in
which apoptosis and necroptosis are blocked.
We have demonstrated that caspase-8 protein is required for
IETD-induced atypical inflammasome activation in Fadd−/−Ripk3−/−
myeloid cells. Knockdown of caspase-8 abolished the ability of
IETD to induce IL-1 production and cell death in Fadd−/−Ripk3−/−
BMDCs stimulated with LPS (Figs. 3B and 5E), indicating that the
presence of inactivated caspase-8 is indispensable for inflammasome
activation. Therefore, IL-1 and IL-18 generation is not an off-target
effect of IETD in Fadd−/−Ripk3−/− cells. Instead, inactive caspase-8
likely serves as a scaffold protein to trigger inflammasome assembly
in those cells, which is supported by studies showing that inactivated
caspase-8 adopts a conformation distinct from active caspase-8
and that the former nucleates ASC for subsequent caspase-1 activation (7). We also observed ASC dimerization in response to either
R848 + IETD or LPS + nigericin treatment in Fadd−/−Ripk3−/−
BMDCs (Fig. 2D). We found that NLRP3 was dispensable for IETDtriggered inflammasome activation in Fadd −/−Ripk3−/− myeloid
cells, as revealed by their normal production of IL-1 and IL-18 (fig.
S7, B and C). Consistent with previous reports that caspase-8 inactivation triggers pyroptosis when apoptosis and necroptosis are inhibited (7, 8), we found that GSDMD contributed to death in
IETD-treated Fadd−/−Ripk3−/− myeloid cells. GSDMD knockout interfered with IETD-induced death in those cells (Fig. 5G), and we
detected a striking inhibitory effect of GSDMD knockout or disulfiram treatment on IETD-triggered IL-1/IL-18 production (Fig. 4, B,
C, E, and F).
Among the downstream targets of caspase-8, RIPK1 is cleaved
by caspase-8 at D324 and D325 to limit apoptosis and necroptosis
(39–41). It has been shown previously that noncleavable RIPK1
mutants contribute to autoinflammatory disease by enhancing
RIPK1-mediated apoptosis and necroptosis (33, 39, 42). Knockout
of RIPK3 abrogates cell death in cells harboring these noncleavable
RIPK1 mutants (33, 39). Intriguingly, cells are extremely sensitive
to the TNF-induced cell death that is inhibited by Nec-1 or a RIPK1
inactive mutant resistant to caspase-8 cleavage (33, 42). We found
that Nec-1 treatment did not prevent IETD-induced cell death in
Fadd−/−Ripk3−/− myeloid cells (Fig. 5H). In addition, RIPK1 levels
were reduced in Fadd−/−Ripk3−/− cells relative to control cells (fig.
S5A). Together, these findings indicate that the cell death induced
by IETD in Fadd−/−Ripk3−/− myeloid cells is unlikely to be mediated
by the excess presence of an uncleavable form of RIPK1.
We also observed that the IETD-induced IL-1/IL-18 production
in Fadd−/−Ripk3−/− cells cannot be recapitulated by replacing IETD
with zVAD, supporting that specific inhibition of caspase-8 protease
activity is essential. One potential reason for the differential outcomes for IETD and zVAD treatment is that IETD-induced inflammasome activation also activates other caspases that are essential
for generating IL-1/IL-18, with the pan-caspase inhibitor zVAD
blocking all these processes. A recent study has revealed that processing of caspase-3 and caspase-7 by caspase-1 is inhibited in cells
in which apoptosis and necroptosis are suppressed (7). We also detected caspase-3 cleavage in Fadd−/−Ripk3−/− myeloid cells treated with
IETD + LPS (Fig. 7E), but neither a caspase-1 inhibitor nor a caspase-3
inhibitor prevented IETD-induced inflammasome activation in those
cells (Fig. 3, C and D, and fig. S10, C and D). Similarly, knockdown
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being fully suppressed by zVAD in Fadd−/−Ripk3−/− BMDCs and
BMDMs (fig. S14, A to D). IETD-induced IL-1 production and cell
death could also be partially inhibited by QVD in Fadd−/−Ripk3−/−
BMDMs (fig. S14, C and D). Next, we explored potential activation of
other caspases/proteases upon IETD treatment in Fadd−/−Ripk3−/−
myeloid cells. We already found that caspase-1, caspase-3, or
caspase-7 alone was dispensable for IETD-induced inflammasome
activation in Fadd−/−Ripk3−/− myeloid cells (Fig. 3C and fig. S10, C
to E). Inclusion of inhibitors for caspase-2 (VDVAD), caspase-6
(VEID), or caspse-9 (LEHD) did not prevent IETD-triggered IL-1
production and cell death (fig. S14). In searching for other proteases
that may account for the effect of IETD in Fadd−/−Ripk3−/− myeloid
cells, we found that the cathepsin-B inhibitor CA-074Me suppressed
IETD-induced IL-1 production (Fig. 9A). CA-074Me also prevented
IETD-triggered cell death in Fadd−/−Ripk3−/− BMDCs (Fig. 9B).
However, no effect was detected when the cathepsin-D inhibitor
pepstatin A was included (Fig. 9, A and B). Cathepsin-B is known
to be suppressed by zVAD (35), implying that the effectiveness of
zVAD in antagonizing IETD activity (fig. S14) could be due to targeting cathepsin-B. To further verify the role of cathepsin-B in LPS +
IETD–induced inflammasome activation, we down-regulated cathepsin-B
by means of specific small interfering RNAs (siRNAs) (Fig. 9C).
Cathepsin-B knockdown reduced IETD-triggered IL-1 production
in Fadd−/−Ripk3−/− dendritic cells (Fig. 9D). Given that cathepsin-B
is known to cleave caspase-11 and participates in inflammasome
activation (36–38), we found that CA-074Me inhibited the cleavage
of caspase-1, GSDMD, and IL-1 (Fig. 9E). In contrast, CA-074Me
did not protect Fadd−/−Ripk3−/− IECs from IETD-induced cell
death (fig. S12C). Neither did CA-074Me confer resistance of
Fadd−/−Ripk3−/− mice to IETD-mediated septic shock (fig. S11G).
Therefore, our results imply that, at least in part, cathepsin-B accounts
for IETD-induced inflammasome activation in Fadd−/−Ripk3−/−
myeloid cells.
Overall, then, our findings provide evidence that autophagy
and cathepsin-B represent one of the intermediate stages between
caspase-8 inactivation, inflammasome formation, and the cell death
triggered by caspase-8 inactivation in myeloid cells when apoptosis
and necroptosis are blocked (fig. S15). Upon caspase-8 inactivation
by IETD, caspase-8 becomes associated with ASC, the complex induces autophagy, and the autophagosome becomes accessible to
cathepsin-B, enabling atypical inflammasome formation for activation
of caspase-1/11. Caspase-1 processes IL-1/IL-18, and caspase-1/11
cleave GSDMD. Cathepsin-B also directly activates caspase-11. Thus,
together, our results reveal a novel process by which caspase-8 inactivation leads to atypical inflammasome activation in myeloid cells
deficient in apoptosis and necroptosis.
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of caspase-3 or caspase-7 failed to inhibit IL-1 production and cell
death in IETD-treated Fadd−/−Ripk3−/− BMDCs (fig. S10E). We also
found that inclusion of inhibitors for caspase-2, caspase-6, and
caspase-9 did not prevent IETD-initiated inflammasome activation
(fig. S14). Thus, the executer of IL-18 and IL-1 processing in IETDtreated Fadd−/−Ripk3−/− myeloid cells is likely not a single commonly
known caspase.
An important finding of our study is the identification of autophagy as an upstream process for inflammasome activation and cell
death in IETD-treated Fadd−/−Ripk3−/− myeloid cells. Autophagy is
well known for its inhibitory role in canonical NLRP3 inflammasome formation (34, 43, 44). Accordingly, our discovery that
autophagy mediates an element of caspase-8 inactivation–induced
inflammasome activation in Fadd−/−Ripk3−/− myeloid cells is unexpected. We observed high-intensity signal of the autophagy-specific
dye DAPGreen in the spherical vesicles induced by LPS + IETD
treatment of Fadd−/−Ripk3−/− cells (Fig. 7 and movie S2), but not in
WT cells undergoing apoptosis, necroptosis, or conventional pyroptosis (fig. S9). Moreover, 3-MA, chloroquine, and ammonium
Wu et al., Sci. Adv. 8, eabn9912 (2022)

11 November 2022

chloride inhibited LPS + IETD–induced IL-1 and IL-18 production in Fadd−/−Ripk3−/− cells (Fig. 8, A and B). This outcome is further supported by the suppression by 3-MA of p20 caspase-1, p17
IL-1, and GSDMD-NT processing in the same cells (Fig. 8D).
3-MA also inhibited caspase-3 cleavage in Fadd−/−Ripk3−/− BMDMs
(Fig. 8E). Moreover, we found that knockout of Beclin-1 attenuated
IETD-triggered IL-1 production in such cells (Fig. 8I). Together,
these results suggest that autophagy precedes assembly of the atypical inflammasome, and it is critical for inflammasome formation.
In addition, since IETD-induced cell death in Fadd−/−Ripk3−/− cells
could be partially abrogated by 3-MA, chloroquine, or ammonium
chloride treatments or Beclin-1 knockout (Fig. 8, C and I), autophagy
also participates in the processes leading to cell death. Autophagy
inhibition had more profound effects on IETD-induced IL-1/IL-18
production than on IETD-triggered cell death in Fadd−/−Ripk3−/−
cells, implying that autophagy represents one of several processes
contributing to cell death.
Previous studies have demonstrated cross-talk between caspase-8
and autophagy, given that caspase-8 cleaves Beclin-1 and Atg3 (45),
13 of 18

Downloaded from https://www.science.org at Thomas Jefferson University on December 01, 2022

Fig. 9. Cathepsin-B mediates the inflammasome activation and caspase cleavage induced by IETD in Fadd−/−Ripk3−/− myeloid cells. (A and B) A cathepsin-B inhibitor suppresses IETD-induced IL-1 generation and cell death in Fadd−/−Ripk3−/− BMDCs. Fadd+/−Ripk3−/− and Fadd−/−Ripk3−/− BMDCs were stimulated with LPS (0.1 g/ml) + IETD
(15 M) in the presence of CA-074Me (50 M) or pepstatin A (50 M, a cathepsin-D inhibitor) for 8 hours. IL-1 production was determined (A), and cell death (as
assessed by LDH release) was quantified (B). *P < 0.05 and ***P < 0.001 for unpaired t test. (C and D) Cathepsin-B knockdown reduces IETD-induced IL-1 in
Fadd−/−Ripk3−/− BMDCs. Fadd−/−Ripk3−/− BMDCs were transfected with control or cathepsin-B–specific siRNAs, before determining cathepsin-B levels (C). Cells were then
treated with LPS (0.1 g/ml) + IETD (10 M) for 8 hours, before IL-1 production was quantitated (D). **P < 0.01 for two-way ANOVA followed by Sidak's multiple comparisons
test. (E) Inhibition of cathepsin-B prevents IETD-triggered caspase-1/11 and GSDMD processing in Fadd−/−Ripk3−/− BMDCs. BMDCs were stimulated with LPS (0.1 g/ml) plus
IETD (10 M) for 6 hours. Culture supernatants (SUP) were precipitated, and whole-cell lysates (WCL) were collected and analyzed for caspase-1 p20, IL-1 p17, GSDMD-NT,
procaspase-1, caspase-11, GSDMD, and pro–IL-1. The experiment (E) was independently repeated three times with similar results.
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One limitation of the present study is that the involvement of
autophagy in IETD-induced inflammasome activation could be restricted to myeloid cells of the Fadd−/−Ripk3−/− background. The
capacity of caspase-8 and FADD to induce inflammasome activation is cell type specific (20, 22). Here, we have found that autophagy
inhibition, cathepsin-B deficiency, or GSDMD knockout impaired IETD-induced IL-1/IL-18 production and cell death in
Fadd−/−Ripk3−/− myeloid cells. These outcomes contrast with the
failure of 3-MA, CA-074-Me, or GSDMD knockout to rescue
IETD-triggered lethality in Fadd−/−Ripk3−/− mice. The discrepancy
between our in vitro and in vivo findings could be due to the different cell types targeted. In scenarios where apoptosis, necroptosis,
and pyroptosis are being genetically manipulated, mouse mortality
is largely determined by nonimmune cells such as IECs (4–8, 33, 47).
In contrast, our study focused on macrophages and dendritic cells
in which phagocytosis and micropinocytosis predominate (48), potentially contributing to the dominant role of autophagy in assembly
of atypical inflammasomes in those cells. We found that inhibition
of autophagy or suppression of cathepsin-B did not prevent IETDinitiated cell death in Fadd−/−Ripk3−/− IECs, implying that autophagyindependent processes operate in IECs and other cell types. Therefore,
how caspase-8 inactivation triggers cell death in Fadd−/−Ripk3−/−
nonmyeloid cells, especially IECs, remains to be elucidated by future studies.
In summary, we have identified autophagy as one of the processes
operating between caspase-8 inactivation and atypical inflammasome
activation in myeloid cells in which apoptosis and necroptosis are
blocked. Inhibition of autophagy prevents IL-1/IL-18 generation
and partially suppresses IETD-induced cell death in Fadd−/−Ripk3−/−
myeloid cells. Suppression of cathepsin-B also alleviates IETDtriggered atypical inflammasome activation. Thus, our results indicate that caspase-8 inactivation triggers autophagy and recruits
cathepsin-B to dictate one of the molecular switches from apoptosis/
necroptosis to pyroptosis in myeloid cells.
MATERIALS AND METHODS

Mice
Fadd−/−FADD:GFPflox mice were generated by J. Zhang (Thomas
Jefferson University, Philadelphia, PA). The Fadd−/−FADD:GFPflox
mice were bred with LysMCre mice (B6.129P2-Lyz2tm1(cre)Ifo/J, #004781,
The Jackson Laboratory, Bar Harbor, ME, USA) to generate Fadd−/−
FADD:GFP flox LysMCre mice. Gsdmd −/− mice (C57BL/6J-Gsdmd em1Vnce/J,
#032663) (49), Casp1/11−/− mice (B6N.129S2-Casp1tm1Flv/J, #016621),
and Becn1flox mice (Becn1tm1.1Yue/J, #028794) were also obtained
from The Jackson Laboratory. The Becn1flox mice were bred with
LysMCre mice to generate Becn1f/fLysMCre mice. Nlrp3−/− mice were
generated by B. Ruffle (Centre National de la Recherche Scientifique,
France) and provided to us by D. Ojcius (Center for Molecular and
Clinical Immunology, Chang Gung University, Taiwan). Ripk3−/−
mice were generated by a CRISPR-Cas9 approach using the following
sequences: single-guide RNA (sgRNA) target 1, 5′-GTCTGTGCACACATAACTCCAGG-3′; sgRNA target 2, 5′-ACAGGCCTAATGCACCCTCACGG-3′. RIPK3 genomic DNA typing was performed
by polymerase chain reaction (PCR) using the following primers,
RIPK3-fwd (5′-GGAGCCTCTTATTTGAAAGG-3′) and RIPK3-rev
(5′-GACAGGCCAAAATCTGCTAG-3′), generating PCR products
of 410 base pairs (bp) for the knockout allele or 1400 bp for the WT
allele: RIPK3-I3F, 5′-GTTCCGGGCACACCACAGAA-3′; RIPK3-E4R,
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whereas inactivation of caspase-8 triggers autophagic cell death (26).
However, there are important differences between those previous
reports and our findings presented here. In contrast to how zVAD
induces autophagy in L929 fibroblasts (26), we found that the effect of IETD treatment cannot be recapitulated by zVAD in terms
of inflammasome activation (Fig. 3A). In addition, we found that
IETD only induced cell death in Fadd−/−Ripk3−/− myeloid cells, but
not in Fadd+/−Ripk3−/− cells, indicating a specific requirement for
blockade of both apoptosis and necroptosis. Notably, p62 has been
shown to promote caspase-8 aggregation on autophagosomes (46),
potentially reflecting a process to initiate inflammasome formation.
FADD suppresses noncleavable caspase-8–mediated ASC speck assembly (20). It is possible that the binding of inactivated caspase-8
to ASC or p62 is inhibited by caspase-8–interacting FADD, so competition between ASC/p62 and FADD for caspase-8 may explain
why inactivated caspase-8 does not trigger inflammasome activation in FADD-sufficient cells.
Another novel finding from our study is the identification of
a role for cathepsin-B in atypical inflammasome activation, as revealed by CA-074Me suppressing IETD-induced caspase-1 activation, GSDMD cleavage, p17 IL-1 generation, and cell death in
Fadd−/−Ripk3−/− BMDCs (Fig. 9, A, B, and E). This novel function is
also supported by the fact that cathepsin-B knockdown reduced
IL-1 generation in IETD-treated Fadd−/−Ripk3−/− BMDCs (Fig. 9D).
Cathepsin-B is suppressed by zVAD (35), consistent with our observation that IETD-triggered IL-1/IL-18 expression and cell death
were effectively inhibited by zVAD (fig. S14), and it explains the
limited inflammasome activation elicited by LPS + zVAD treatment
(figs. S2E and S13). Cathepsin-B binds NLRP3 to activate the NLRP3
inflammasome (38). It has also been shown to directly cleave and
activate caspase-11 (37), which may contribute to the caspase-11
activation observed in the present study. Cathepsin-B also participates in the activation of caspase-1 and caspase-11, as well as IL-1/
IL-18 secretion in microglia independently of NLRP3 (36). In contrast to canonical inflammasome activation, lysosome destabilization is not involved in the initiation of this type of inflammation
(36). Similar to those previous results, our observations suggest that
cathepsin-B is the protease that mediates atypical inflammasome
activation following NLRP3-indepdendent caspase-8 inactivation
in Fadd−/−Ripk3−/− myeloid cells.
We suggest that cathepsin-B acts downstream of autophagy.
Our proposed scenario is that following autophagosome maturation or cytosolic entry of cathepsin-B, the caspase-8–ASC platform
becomes accessible to cathepsin-B in Fadd−/−Ripk3−/− myeloid cells
(fig. S15). Cathepsin-B activity contributes to inflammasome activation, leading to activation of caspase-1 and caspase-11, processing of IL-1/IL-18, and generation of GSDMD-M (Fig. 9E). Further
studies are required to elucidate the exact sequence of biochemical
and cellular steps from caspase-8 inactivation to autophagosome
formation, followed by cathepsin-B association and atypical inflammasome assembly in Fadd−/−Ripk3−/− myeloid cells. It should also
be noted that residual IETD-mediated inflammasome activation
was observed when we inhibited autophagy (Fig. 8, D, E, G, and I)
or upon cathepsin-B suppression (Fig. 9, B and D), indicating that
autophagy and cathepsin-B may not be the only pathway operating
downstream of caspase-8 inactivation in Fadd−/−Ripk3−/− myeloid
cells. Identification of other parallel processes involved in atypical
inflammasome activation in Fadd−/−Ripk3−/− myeloid cells will help
establish a complete picture of this unusual event.
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Reagents and antibodies
Purified LPS, R848, poly(I:C), CpG, nigericin, and heat-killed Candida
albicans were purchased from InvivoGen (San Diego, CA, USA).
A TNF- mouse ELISA kit, an IL-6 mouse ELISA kit, an IL-1 mouse
ELISA kit, and Lipofectamine 2000 were purchased from Thermo
Fisher Scientific (Waltham, MA, USA). Ac-YVAD-cmk, Nec-1,
CHAPS, MG132, dexamethasone, chloroquine, tubacin, colchicine,
3-MA, and emricasan (SML2227) were all purchased from SigmaAldrich (St. Louis, MO). Dimethyl sulfoxide (DMSO) was purchased
from Merck Millipore (Billerica, MA). Recombinant granulocytemacrophage colony-stimulating factor (GM-CSF) was purchased
from PeproTech (Rocky Hill, NJ, USA). Z-IETD-fmk was obtained
from R&D Systems (Minneapolis, MN, USA), MedChemExpress
(Monmouth Junction, NJ, USA), and Taiclone Biotech Corp. (Taipei,
Taiwan). z-VAD-FMK was obtained from Bachem (Bubendorf,
Switzerland). Q-VD-Oph and Ac-DEVD-CHO were obtained from
CiteAb (Bath, UK). VX-765 and Z-VDVAD-FMK were purchased
from BioVision (Milpitas, CA, USA). Z-VEID-FMK and Z-LEHDFMK were purchased from Abcam (Cambridge, UK). CA-074Me
was obtained from MedChemExpress. DAPGreen was purchased
from Dojindo Molecular Technologies Inc. (Rockville, MD).
Anti-mouse RIPK3 (95702, RRID:AB_2721823), anti-pIKK
(2078, RRID:AB_2079379), anti-IKK (8943, RRID:AB_11024092),
anti-pJNK (9251, RRID:AB_331659), anti-JNK (9252,
RRID:AB_2250373), anti-pp38 (9211, RRID:AB_331641), anti-p38 (9218,
RRID:AB_10694846), anti-pERK (9101, RRID:AB_331646), antiERK(9102,RRID:AB_330744),anti-Atg5 (12994, RRID:AB_2630393),
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anti–Beclin-1 (3495, RRID:AB_1903911), anti–caspase-3 (9662,
RRID:AB_331439), anti–cleaved caspase-3 (9661, RRID:AB_2341188),
anti-mouse caspase-8 (4927, RRID:AB_2068301), and anti–cleaved
caspase-8 (9429, RRID:AB_2068300) were purchased from
Cell Signaling Technology (Danvers, MA). Anti-FADD (05-486,
RRID:AB_11212178) was purchased from Merck Millipore (Billerica,
MA). Anti-ASC (AL177) (AG-25B-0006, RRID:AB_2490440),
anti-NLRP3 (Cryo-2) (AG-20B-0014, RRID:AB_2490202), and anti–
caspase-1 (Casper-1) (AG-20B-0042, RRID:AB_2490248) were
obtained from AdipoGen Life Science (San Diego, CA). Anti–pro–
IL-1 (AF-401-NA, RRID:AB_416684) was purchased from R&D Systems
(Minneapolis, MN). Anti–-actin (sc-69879, RRID:AB_1119529),
anti-IB (sc-371, RRID:AB_2235952), anti–IL-18 (sc-6179,
RRID:AB_2123799), anti–cathepsin-B (sc-365558, RRID:AB_10842446),
and anti–caspase-1 (sc-514, RRID:AB_2068895) were purchased
from Santa Cruz Biotechnology (Dallas, TX). Anti-HSP90 (610419,
RRID:AB_397799) and anti-RIPK1 (610459, RRID:AB_3978320)
were obtained from BD Biosciences (Franklin Lakes, NJ). AntiGSDMD (ab209845, RRID:AB_2783550), anti–caspase-8 (ab138485,
RRID:NA), and anti–cathepsin-B (ab214428, RRID:AB_2848144)
were purchased from Abcam (Cambridge, UK). Anti–caspase-11
(17D9) (NB120-10454, RRID:AB_788441) was purchased from
Novus Biologicals (Centennial, CO).
siGENOME mouse Casp8 siRNA SMARTPool (D-043044),
mouse Becn1 siRNA SMARTPool (D-055895), and mouse Atg5
siRNA SMARTPool (M-064838) were obtained from Horizon Discovery Ltd. (Cambridge, UK). Cathepsin-B siRNA (sc-29933) was
purchased from Santa Cruz Biotechnology (Dallas, TX). The target
sequences for mouse caspase-8 were as follows: 5′-AAUGUAAGCUGGAAGAUGA-3′, 5′-GAACUGCGUUUCCUACCGA-3′, 5′GAAGUGAGCGAGUUGGAAU-3′, and 5′-AGAGUUGUCUUUAUGCUAU-3′. The siRNA sequences for Atg5 were as follows: 5′CCAAUUGGUUUACUAUUUG-3′, 5′-CGAAUUCCAACUUGCUUUA-3′, 5′-UUAGUGAGAUAUGGUUUGA-3′, and 5′GCAUAAAAGUCAAGUGAUC-3′. The siRNA sequences for Becn-1
were as follows: 5′-GGAAGAGGGCUAACUCAGGA-3′, 5′GGAGUGGAAUGAAAUCAAU-3′, 5′-GGGAGUAUAGUGAGU
UUAA-3′, and 5′-GUACCGACUUGUUCCCUAU-3′.
Cell culture
Bone marrow cells were collected from tibias and femurs of age- and
sex-matched 8- to 12-week-old mice described in the “Mice” section
and cultured in either complete Dulbecco’s Modified Eagle’s
Medium (DMEM) [supplemented with 10% fetal calf serum, 10 mM
glutamine, penicillin (100 U/ml), streptomycin (100 g/ml), and
50 M 2-mercaptoethanol] with 20% L929 conditioned medium for
6 days to generate BMDMs or complete RPMI (same supplements as
for complete DMEM) containing GM-CSF (15 ng/ml) for 8 days to
generate BMDCs.
Adenosine triphosphate (ATP) cell viability assays were conducted using the CellTiter-Glo Luminescent Cell Viability Assay
Kit (G7570, Promega, Fitchburg, WI). Luminescence was quantitated using the Victor3 1420 Multilabel Counter (PerkinElmer,
Shelton, CT). Cell death was also determined by PI staining (33)
and quantitated under fluorescence microscopy or by using a
flow cytometer. Alternatively, lactate dehydrogenase (LDH)
release was used to determine the extent of cell death using Cytotoxicity LDH Assay Kit-WST (CK12, Dojindo Molecular Technologies Inc.).
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5′-GCAGGAGCGGAGGGTTCAAG-3′. The Ripk3−/− mice were
bred with Fadd−/−FADD:GFPflox mice to generate Ripk3−/−Fadd−/−
mice. PCR primers for WT FADD genomic DNA were FADDE1F
(5′-CACTGCCATGGACCCATTCC-3′) and FADDE1R (5′-GCGCAGCGAGGCCAGCAACT-3′). For FADD-deleted genomic DNA,
they were Neo41F (5′-CTTGGGTGGAGAGGCTATTC-3′) and
Neo210R (5′-CAGCCACGATAGCCGCGCTG-3′). The phenotypes
of Ripk3−/− Fadd−/− mice, characterized by lymphadenopathy and
splenomegaly, were comparable to reports of other Ripk3−/− Fadd−/−
mice (47). Nlrp3−/− mice, Casp1/11 −/− mice, Gsdmd −/− mice, or
Becn1f/fLysMCre mice were further bred with Fadd+/−Ripk3−/− or
Fadd−/−Ripk3−/− mice to generate mice strains for the present study.
All mouse experiments were conducted with approval (protocol
#17-12-1172) from the Institutional Animal Care and Utilization
Committee, Academia Sinica.
PCR primers for WT Nlrp3 genomic DNA were Nlrp3IntronF
(5′-GCTCAGGACATACGTCTGGA-3′) and Nlrp3E1R (5′-CCTTGAAGATGTGGACCTCA-3′). For Nlrp3-deleted genomic DNA,
they were Nlrp3IntronF and Nlrp3MutantR (5′- TTGTAGTTGCCGTCGTCCTT-3′). PCR primers for WT Casp1/11 genomic DNA
were mCasp1WTF (5′-GAGACATATAAGGGAGAAGGG-3′) and
mCasp1ComR (5′-ATGGCACACCACAGATATCGG-3′). For Casp1/11deleted genomic DNA, they were mCasp1MutF (5′-TGCTAAAGCGCATGCTCCAGACTG-3′) and mCasp1ComR. PCR primers
for WT Gsdmd genomic DNA were mGsdmdSeqF (5′- GAACCATCTCTCCAGCCTGA-3′) and mGSDMDWTR (5′-ATGCCTGACAACATCAC-3′). For Gsdmd-deleted genomic DNA, they
were mGsdmdSeqF and mGSDMDMutR (5′-CTCTGCATCCACACACCTT-3′). PCR primers for Becn1 Flox were mBecn1F
(5′-TCTTCACCTCCACCACCAAG-3′) and mBecn1R (5′-CCCGGTCCAGGATCTTGAAG-3′).
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IETD-induced septic shock
Age- and sex-matched 8- to 12-week-old male and female
Fadd+/−Ripk3−/− and Fadd−/−Ripk3−/− mice were used. The matched
Fadd+/−Ripk3−/− and Fadd−/−Ripk3−/− mice were mostly littermates.
Mice were intraperitoneally injected with z-IETD-fmk (5 g/g) in a
total volume of 200 l endotoxin-free phosphate-buffered saline
(PBS). Three hours after injection, mouse blood serum was collected
and IL-6 levels were determined using an ELISA kit. Peritoneal
lavage was then conducted by rinsing the peritoneum with 0.5 ml of
PBS. Cells from peritoneal lavages were stained with PI, and cytokine levels were determined using ELISA kits. For septic shock, the
survival of mice was monitored for 30 hours after IETD administration. Age- and sex-matched 8- to 10-week-old Fadd+/−Ripk3−/− and
Fadd−/−Ripk3−/− mice carrying Nlrp3−/−, Casp1/11−/−, Gsdmd−/−, or
Becn1f/fLysMCre were further used for septic shock study. Each set
of experiment was designed to contain a minimum of five pairs of
mice, but a lower number of mice were used (fig. S11, D and F) due
to difficulty to obtain sufficient specific triple knockout mice. Also,
because of the limited number of the triple knockout mice generated,
no experimental randomization was applied. Reagent administration (IETD) and result recording (death monitor) were conducted
by different persons, but blinding was not strictly implemented as
the readout (mouse death) was clear-cut.
ASC cross-linking
BMDCs were treated with R848 + IETD for 8 hours. Cells were
washed with ice-cold PBS and then incubated in buffer A [20 mM
Hepes (pH 7.2), 10 mM KCl, 1.5 mM MgCl2, 320 mM sucrose, 1 mM
EDTA, and 1 mM EGTA]. Cell lysates were centrifuged to remove
cell debris, and the supernatant was then added to a double volume
of buffer A before being filtered through 5-m mesh. Filtered samples
were added to a double volume of CHAPS buffer [20 mM Hepes (pH 7.5),
5 mM MgCl2, 0.5 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride,
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and 0.1% CHAPS] and then centrifuged at 5000g for 8 min. The pellets
were resuspended in CHAPS buffer and cross-linked by means of
dextran sulfate sodium (4 mM) at room temperature for 30 min.
Samples were then boiled before being resolved by SDS-PAGE.
Microscopy
For time-lapse fluorescence microscopy, BMDMs were seeded in
96-well plates. Cells were stimulated with LPS (0.1 g/ml) and IETD
(10 M) for 1 hour before adding PI (0.2 g/ml). Images were then
acquired using an MD ImageXpress Micro XL microscope over the
course of another 15 hours at intervals of 30 min. For DAPGreen
staining, BMDMs were stained with DAPGreen (0.2 M) for 30 min
and then stimulated with LPS (0.1 g/ml) and IETD (10 M) in the
absence or presence of 3-MA (1 mM) for 16 hours. Cell nuclei were
stained with Hoechst 33342 Ready Flow reagent. Images were captured using an Olympus IX71 microscope. Average DAPGreen
fluorescence intensity in a cell defined by Hoechst staining was
quantified by ImageJ. The fold change in fluorescence intensity induced by IETD was compared to that by LPS alone.
IEC culture
Mouse IECs were cultured using IntestiCult Organoid Growth Medium (06005, StemCell Technologies, Vancouver, Canada) following
the manufacturer’s protocol. In brief, intestine was isolated from
age- and sex-matched Fadd+/−Ripk3−/− or Fadd−/−Ripk3−/− mice,
washed, and cut open longitudinally. The washed intestinal sheet was
cut into 2-mm pieces and then washed 20 times. The tissue pieces
were resuspended in Gentle Cell Dissociation Reagent (07174,
StemCell) and incubated for 15 min at room temperature. The released intestinal crypts were isolated; aliquoted into 500, 1500, and
3000 crypts per fraction; and pelleted by centrifugation. IntestiCult
Organoid Growth Medium was then added to the pellets, followed
by Matrigel Matrix (356231, Corning), and each resuspended pellet
was placed onto six wells of a 24-well plate. The intestinal crypts
were analyzed for their response to LPS + IETD treatment after culturing for 7 to 10 days. LDH release was quantified 24 hours after
LPS + IETD treatment.
Statistics
In vitro data were collected randomly but not blind. No samples or
animals were excluded from this study. Two or three technical replicates were used for the in vitro experiment, and three independent
experiments were conducted. Data met the assumptions of applied
statistical tests (i.e., normal distributions). Statistical analyses were
conducted in Prism 5 (GraphPad). Results were evaluated by twoway analysis of variance (ANOVA) followed by Sidak's or Tukey’s
multiple comparisons test, as described in the respective figure legends.
A log-rank (Mantel-Cox) test was used to compare mouse survival.
Data are presented as means + SD. P values of <0.05 were considered
significant, as indicated in the figure legends.
SUPPLEMENTARY MATERIALS

Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abn9912
View/request a protocol for this paper from Bio-protocol.
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Western blot
For immunoblotting, the culture supernatants were isolated and
precipitated by cold acetone (−20°C), and then cells were lysed
using whole-cell extract buffer [25 mM Hepes (pH 7.9), 300 mM
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, and
0.1% Triton X-100] on ice for 30 min. Supernatants were separated
by centrifugation at 13,200 rpm for 10 min at 4°C. The protein concentrations were determined by Bio-Rad protein assay (#500-00006).
Samples were denatured and analyzed by SDS–polyacrylamide
gel electrophoresis (SDS-PAGE) in running buffer (0.025 M tris,
0.192 M glycine, and 0.1% SDS). The gel was transferred to polyvinylidene difluoride membrane (Millipore) in transfer buffer (25 mM
tris, 192 mM glycine, and 20% methanol) at 400 mA for 100 min
at 4°C. Membranes were blocked with SuperBlock T20 (SigmaAldrich) to detect anti-phosphate antibody or blocking buffer [5%
nonfat milk and 0.1% Tween 20 in a TBST buffer of 50 mM tris-HCl
(pH 7.4) and 150 mM NaCl] at room temperature for 30 min, before
being incubated overnight at 4°C with specific primary antibodies
at indicated dilutions. The membranes were washed three times
with wash buffer (0.1% Tween 20 in TBST buffer) at room temperature
for 10 min before incubating them with horseradish peroxidase–
conjugated secondary antibodies in blocking buffer at room temperature for 1 hour. After washing, the membranes were developed
with ECL Western blot detection reagents (Advansta, K-12045-D50),
and signals were detected by x-ray film (Fujifilm).
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